QL
IMVT icon

Quarry LP’s Immunovant IMVT Stock Holding History

Quarry LP’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.81K Buy
+47
New +$1.43K ﹤0.01% 1705
2026
Q1 		– Sell
-3,000
Closed -$76.3K – 1825
2025
Q4 		$76.3K Buy
3,000
+1,461
+95% +$32.6K 0.01% 528
2025
Q3 		$24.8K Sell
1,539
-2,249
-59% -$36.4K 0.01% 1274
2025
Q2 		$60.6K Buy
+3,788
New +$57.3K 0.01% 773

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Quarry LP's IMVT Position: Q2 2026 in Review

Quarry LP opened a new position in Immunovant (IMVT) in Q2 2026: 47 shares worth $1.81K. The stake represents ﹤0.01% of the portfolio and ranks #1705 among its holdings. This is a return to the name: Quarry LP previously reported a position in IMVT as recently as Q4 2025.

Quarry LP first reported a position in IMVT in Q2 2025 and has held it in 4 quarters since. The position peaked at $76.3K in Q4 2025. 227 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • Quarry LP held 47 shares of Immunovant worth $1.81K as of Q2 2026.
  • Immunovant was a new Quarry LP position in Q2 2026.
  • Immunovant made up ﹤0.01% of Quarry LP's portfolio in Q2 2026, its #1705 holding.
  • Quarry LP first reported a position in Immunovant in Q2 2025 and has held it in 4 quarters since.
  • Quarry LP's Immunovant position peaked at $76.3K in Q4 2025.
  • 227 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.